CVE-2026-21974
CVE-2026-21974
Vexday Risk Score
13Bajo
Decisión SSVC (CISA)
Track
Sin señal de explotación → monitorear
CVSS 5.3EPSS 0.2%KEV nãoPoC —Nuclei —Metasploit —Patch referenciado
Ciclo de vida
20 ene 2026Publicada en NVD
Recomendación: Monitorear — sin señal de explotación por ahora.
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Productos afectados
Oracle Corporation · Oracle Life Sciences Central Designer